USP General Chapter <1231> — Water for Pharmaceutical Purposes — is the foundational regulatory reference for pharmaceutical water quality in the United States. Understanding its requirements is essential for laboratory professionals, compounding pharmacy quality teams, pharmaceutical manufacturers, and anyone procuring or using pharmaceutical-grade water in regulated operations.
Categories of Pharmaceutical Water Under USP <1231>
USP <1231> defines several categories of pharmaceutical water: Purified Water (PW), Water for Injection (WFI), Bacteriostatic Water for Injection (BWFI), Sterile Water for Injection (SWFI), Sterile Water for Inhalation, Sterile Water for Irrigation, and others. Each category has specific quality attributes, permitted uses, and testing requirements defined in their individual USP monographs.
Bacteriostatic Water for Injection — Key Requirements
Bacteriostatic Water for Injection (BWFI) per USP monograph must be sterile water containing one or more suitable antimicrobial agents — most commonly 0.9% benzyl alcohol. Key quality attributes include: sterility (USP <71> compliant), endotoxin level below 0.5 EU/mL (note: many premium suppliers like Renew Lab Group maintain levels well below this at <0.1 EU/mL), pH within specified range, and documented preservative concentration by validated analytical method (typically HPLC).
Testing Requirements for Pharmaceutical Water
Comprehensive pharmaceutical water testing per USP standards includes: HPLC purity analysis, endotoxin testing by LAL method (USP <85>), sterility testing (USP <71>), TOC analysis (USP <643>), conductivity, pH, and microbiological limits testing. Renew Lab Group performs all required tests on every production batch, with results documented in a Certificate of Analysis accompanying each order.
